Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 51

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Germ line mutations associated with leukemias

Porter, Christopher C.·2016·Hematology
DOI 10.1182/asheducation-2016.1.302
Open this paper in CoChat — free account

Abstract

Several genetic syndromes have long been associated with a predisposition to the development of leukemia, including bone marrow failure syndromes, Down syndrome, and Li Fraumeni syndrome. Recent work has better defined the leukemia risk and outcomes in these syndromes. Also, in the last several years, a number of other germ line mutations have been discovered to define new leukemia predisposition syndromes, including ANKRD26, GATA2, PAX5, ETV6, and DDX41. In addition, data suggest that a substantial proportion of patients with therapy related leukemias harbor germ line mutations in DNA damage response genes such as BRCA1/2 and TP53. Recognition of clinical associations, acquisition of a thorough family history, and high index-of-suspicion are critical in the diagnosis of these leukemia predisposition syndromes. Accurate identification of patients with germ line mutations associated with leukemia can have important clinical implications as it relates to management of the leukemia, as well as genetic counseling of family members.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/asheducation-2016.1.302

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 51

  1. Moriyama, 2015, Inherited genetic variation in childhood acute lymphoblastic leukemia, Blood, 125, 3988, 10.1182/blood-2014-12-580001 · DOI
  2. Duxin, 2015, What is the DNA repair defect underlying Fanconi anemia?, Curr Opin Cell Biol, 37, 49, 10.1016/j.ceb.2015.09.002 · DOI
  3. Alter, 2014, Fanconi anemia and the development of leukemia, Best Pract Res Clin Haematol, 27, 214, 10.1016/j.beha.2014.10.002 · DOI
  4. Schulz, 2012, Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms, J Med Genet, 49, 422, 10.1136/jmedgenet-2011-100674 · DOI
  5. Churpek, 2016, Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia, Cancer, 122, 304, 10.1002/cncr.29615 · DOI
  6. Alter, 2010, Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study, Br J Haematol, 150, 179, 10.1111/j.1365-2141.2010.08212.x · DOI
  7. Roberts, 2014, Haematopoietic development and leukaemia in Down syndrome, Br J Haematol, 167, 587, 10.1111/bjh.13096 · DOI
  8. Maloney, 2015, Down syndrome preleukemia and leukemia, Pediatr Clin North Am, 62, 121, 10.1016/j.pcl.2014.09.009 · DOI
  9. Maloney, 2010, Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children’s Oncology Group, Blood, 116, 1045, 10.1182/blood-2009-07-235291 · DOI
  10. Hertzberg, 2010, Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group, Blood, 115, 1006, 10.1182/blood-2009-08-235408 · DOI
  11. Li, 2014, Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia, Nature, 508, 98, 10.1038/nature13115 · DOI
  12. Harrison, 2014, An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome, Leukemia, 28, 1015, 10.1038/leu.2013.317 · DOI
  13. Harrison, 2010, Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfürt-Münster study group, Br J Haematol, 151, 132, 10.1111/j.1365-2141.2010.08314.x · DOI
  14. Niemeyer, 2014, RAS diseases in children, Haematologica, 99, 1653, 10.3324/haematol.2014.114595 · DOI
  15. Chang, 2014, Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia, Blood, 124, 2487, 10.1182/blood-2014-03-300319 · DOI
  16. Chang, 2013, Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice, J Clin Invest, 123, 335, 10.1172/JCI63193 · DOI
  17. Akutagawa, 2016, Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras, Leukemia, 30, 1335, 10.1038/leu.2016.14 · DOI
  18. Spinner, 2014, GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity, Blood, 123, 809, 10.1182/blood-2013-07-515528 · DOI
  19. Wlodarski, 2016, Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents, Blood, 127, 1387, 10.1182/blood-2015-09-669937 · DOI
  20. Latger-Cannard, 2016, Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders, Orphanet J Rare Dis, 11, 49, 10.1186/s13023-016-0432-0 · DOI
  21. Antony-Debré, 2015, Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia, Blood, 125, 930, 10.1182/blood-2014-06-585513 · DOI
  22. Pippucci, 2011, Mutations in the 5′ UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2, Am J Hum Genet, 88, 115, 10.1016/j.ajhg.2010.12.006 · DOI
  23. Noris, 2011, Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families, Blood, 117, 6673, 10.1182/blood-2011-02-336537 · DOI
  24. Noris, 2013, ANKRD26-related thrombocytopenia and myeloid malignancies, Blood, 122, 1987, 10.1182/blood-2013-04-499319 · DOI
  25. Zhang, 2015, Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy, Nat Genet, 47, 180, 10.1038/ng.3177 · DOI
  26. Noetzli, 2015, Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia, Nat Genet, 47, 535, 10.1038/ng.3253 · DOI
  27. Topka, 2015, Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia, PLoS Genet, 11, e1005262, 10.1371/journal.pgen.1005262 · DOI
  28. Moriyama, 2015, Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study, Lancet Oncol, 16, 1659, 10.1016/S1470-2045(15)00369-1 · DOI
  29. Wang, 2016, Common genetic variation in ETV6 is associated with colorectal cancer susceptibility, Nat Commun, 7, 11478, 10.1038/ncomms11478 · DOI
  30. McBride, 2014, Li-Fraumeni syndrome: cancer risk assessment and clinical management, Nat Rev Clin Oncol, 11, 260, 10.1038/nrclinonc.2014.41 · DOI
  31. Hof, 2011, Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia, J Clin Oncol, 29, 3185, 10.1200/JCO.2011.34.8144 · DOI
  32. Salmoiraghi, 2016, Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival, Haematologica, 101, e245, 10.3324/haematol.2015.137059 · DOI
  33. Irving, 2016, Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia, Blood, 128, 911, 10.1182/blood-2016-03-704973 · DOI
  34. Holmfeldt, 2013, The genomic landscape of hypodiploid acute lymphoblastic leukemia, Nat Genet, 45, 242, 10.1038/ng.2532 · DOI
  35. Wimmer, 2014, Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’ (C4CMMRD), J Med Genet, 51, 355, 10.1136/jmedgenet-2014-102284 · DOI
  36. Ripperger, 2016, Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome, Eur J Med Genet, 59, 133, 10.1016/j.ejmg.2015.12.014 · DOI
  37. Smith, 2004, Mutation of CEBPA in familial acute myeloid leukemia, N Engl J Med, 351, 2403, 10.1056/NEJMoa041331 · DOI
  38. Tawana, 2015, Disease evolution and outcomes in familial AML with germline CEBPA mutations, Blood, 126, 1214, 10.1182/blood-2015-05-647172 · DOI
  39. Li, 2015, Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis, Eur J Haematol, 94, 439, 10.1111/ejh.12450 · DOI
  40. Cardoso, 2016, Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia, Leukemia, 30, 2083, 10.1038/leu.2016.124 · DOI
  41. Lewinsohn, 2016, Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies, Blood, 127, 1017, 10.1182/blood-2015-10-676098 · DOI
  42. Polprasert, 2015, Inherited and somatic defects in DDX41 in myeloid neoplasms, Cancer Cell, 27, 658, 10.1016/j.ccell.2015.03.017 · DOI
  43. Li, 2016, Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia, Haematologica, 101, e228, 10.3324/haematol.2015.139790 · DOI
  44. Shah, 2013, A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia, Nat Genet, 45, 1226, 10.1038/ng.2754 · DOI
  45. Auer, 2014, Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A, Leukemia, 28, 1136, 10.1038/leu.2013.363 · DOI
  46. Saliba, 2015, Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies, Nat Genet, 47, 1131, 10.1038/ng.3380 · DOI
  47. Harutyunyan, 2016, Germline RBBP6 mutations in familial myeloproliferative neoplasms, Blood, 127, 362, 10.1182/blood-2015-09-668673 · DOI
  48. Guo, 2014, Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1, Blood, 124, 2767, 10.1182/blood-2014-08-596445 · DOI
  49. Kirwan, 2012, Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia, Am J Hum Genet, 90, 888, 10.1016/j.ajhg.2012.03.020 · DOI
  50. Roccaro, 2016, Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia, Blood, 127, 2598, 10.1182/blood-2015-11-680199 · DOI
  51. Perez-Garcia, 2013, Genetic loss of SH2B3 in acute lymphoblastic leukemia, Blood, 122, 2425, 10.1182/blood-2013-05-500850 · DOI

Cited by

Metadata

Authors
Porter, C. C.
Venue
Hematology
Publisher
American Society of Hematology
Published
2016-12-02
Volume
2016
Issue
1
Pages
302-308
ISSN
  • 1520-4391
  • 1520-4383
DOI
10.1182/asheducation-2016.1.302
Cited by
51
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review